Cure Cdkl5 Epilepsy Foundation
Funding Overview
From IRS Form 990 filings · 2024
Total received
$100K
Foundation funders
1
Grants recorded
1
Years covered
2024
Who funds Cure Cdkl5 Epilepsy Foundation?
Cure Cdkl5 Epilepsy Foundation is funded by 1 grantmaker, led by The Ogunlesi Family Foundation ($100K). In total, IRS Form 990 filings record $100K in grants to Cure Cdkl5 Epilepsy Foundation between 2024.
| Funder | Total given | Grants | Years |
|---|---|---|---|
| The Ogunlesi Family Foundation | $100,000 | 1 | 2024 |
Funding over time
Grant dollars and counts received per year
What grants has Cure Cdkl5 Epilepsy Foundation received?
Individual grants from IRS Form 990 filings, newest first
| Year | Funder | Purpose | Amount |
|---|---|---|---|
| 2024 | The Ogunlesi Family Foundation | PROGRAM SUPPORT | $100,000 |
Frequently Asked Questions
Who funds Cure Cdkl5 Epilepsy Foundation?
Cure Cdkl5 Epilepsy Foundation is funded by 1 grantmaker, led by The Ogunlesi Family Foundation ($100K). In total, IRS Form 990 filings record $100K in grants to Cure Cdkl5 Epilepsy Foundation between 2024.
Who is Cure Cdkl5 Epilepsy Foundation's largest funder?
The Ogunlesi Family Foundation is the largest recorded funder of Cure Cdkl5 Epilepsy Foundation, with $100K across 1 grant (2024).
How much grant funding has Cure Cdkl5 Epilepsy Foundation received?
IRS 990 filings record $100K in grants to Cure Cdkl5 Epilepsy Foundation across 1 grants from 1 funders between 2024. Filings are published on a delay, so recent grants may not appear yet.
Looking for funders like Cure Cdkl5 Epilepsy Foundation's?
Grantable's AI matches your organization against 200,000+ grantmakers — including every funder on this page — using their real giving history.
You, clicking into all 1 funders
~7 min
at ~7 min per funder profile
Your agents, the same 1
under a minute
every profile evaluated and scored, with reasoning
Grant data is drawn from IRS Form 990 filings via Grantable's GrantGraph™. Filings are published on a delay; recent grants may not appear yet.